{"id":344661,"date":"2025-08-24T13:41:01","date_gmt":"2025-08-24T13:41:01","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-novartis-ag\/"},"modified":"2025-08-24T13:41:01","modified_gmt":"2025-08-24T13:41:01","slug":"how-to-buy-novartis-ag","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-novartis-ag\/","title":{"rendered":"How to buy Novartis AG (NVS) shares &#8211; Investment in Novartis AG (NVS) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334027,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-344661","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy Novartis AG (NVS) Shares - Investment in Novartis AG (NVS) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy Novartis AG (NVS) Shares - Investment in Novartis AG (NVS) Stock"},"description":"Learn how to buy Novartis AG (NVS) shares and invest in this pharmaceutical giant. Discover current stock price, risks, and growth potential for 2025-2030.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to buy Novartis AG (NVS) shares and invest in this pharmaceutical giant. Discover current stock price, risks, and growth potential for 2025-2030."},"intro":"Imagine owning a piece of one of the world's largest pharmaceutical companies that's transforming medicine every day. Novartis AG represents stability, innovation, and global healthcare impact\u2014perfect for investors seeking both growth and defensive positioning. Let's explore why NVS stock deserves your attention and how you can become part of this medical revolution.","intro_source":{"label":"Intro","type":"text","formatted_value":"Imagine owning a piece of one of the world's largest pharmaceutical companies that's transforming medicine every day. Novartis AG represents stability, innovation, and global healthcare impact\u2014perfect for investors seeking both growth and defensive positioning. Let's explore why NVS stock deserves your attention and how you can become part of this medical revolution."},"body_html":"<h2>\ud83d\udcc8 Novartis Stock Analysis: Current Price and Market Position<\/h2> <p>As of August 24, 2025, Novartis AG (NVS) trades at <strong>$126.98<\/strong>\u2014a strong position reflecting the company's solid performance and market confidence. This Swiss pharmaceutical giant isn't just another stock; it's a cornerstone of global healthcare innovation.<\/p> <p><strong>Mark Your Calendar: November 4, 2025<\/strong> is your next critical date. That's when Novartis releases its Q3 earnings report, and historically, these announcements create significant price movements. The company's last earnings on July 17, 2025, showed impressive results with double-digit sales growth and core margin expansion.<\/p> <h3>How Earnings Reports Impact NVS Stock<\/h3> <table> <thead> <tr><th>Date<\/th><th>Event<\/th><th>Price Impact<\/th><th>Duration<\/th><\/tr> <\/thead> <tbody> <tr><td>July 17, 2025<\/td><td>Q2 Earnings Beat<\/td><td>+3.2%<\/td><td>2 days<\/td><\/tr> <tr><td>April 22, 2025<\/td><td>Q1 Results<\/td><td>+2.1%<\/td><td>1 week<\/td><\/tr> <tr><td>February 5, 2025<\/td><td>Annual Report<\/td><td>+4.8%<\/td><td>3 days<\/td><\/tr> <tr><td>October 29, 2024<\/td><td>Q3 Earnings<\/td><td>-1.5%<\/td><td>Minor dip<\/td><\/tr> <tr><td>July 18, 2024<\/td><td>Q2 Results<\/td><td>+3.6%<\/td><td>Sustained growth<\/td><\/tr> <tr><td>April 23, 2024<\/td><td>Q1 Performance<\/td><td>+2.3%<\/td><td>Steady climb<\/td><\/tr> <\/tbody> <\/table> <p>The pattern shows Novartis typically experiences positive momentum after strong earnings, with occasional minor corrections that often present buying opportunities.<\/p>  [cta_green text=\"Start trading\"]<h2>\ud83d\udcca 6-Month Price Journey: January-August 2025<\/h2> <p>Novartis shares have demonstrated remarkable resilience and growth over the past six months:<\/p> <ul> <li><strong>January 2025<\/strong>: Started around $96.91, surged +7.61% as investors recognized the company's restructuring benefits<\/li> <li><strong>February 2025<\/strong>: Continued momentum with +4.13% growth, reaching $113 high on strong product pipeline news<\/li> <li><strong>March 2025<\/strong>: Steady +2.23% gain as market digested Q1 expectations<\/li> <li><strong>April 2025<\/strong>: Volatile period (+1.80%) with wider swings between $97.72-$114.70<\/li> <li><strong>May 2025<\/strong>: Solid +2.00% growth amid positive clinical trial results<\/li> <li><strong>June 2025<\/strong>: Strong +4.54% rebound as acquisition news boosted confidence<\/li> <li><strong>July 2025<\/strong>: Minor correction of -3.62% due to profit-taking after strong run<\/li> <li><strong>August 2025<\/strong>: Recovery to current $126.98, showing investor confidence<\/li> <\/ul> <p><strong>Total 6-month gain: Approximately 28%<\/strong>\u2014outperforming many pharmaceutical peers and demonstrating why NVS remains a favorite among growth investors.<\/p>  <h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2> <p>Based on current analyst projections and company performance, here's what to expect:<\/p> <ul> <li><strong>2025 Year-End<\/strong>: $129-135 (strong holiday quarter and pipeline developments) \u2192 <strong>BUY<\/strong><\/li> <li><strong>2026 Target<\/strong>: $140-150 (successful integration of recent acquisitions)<\/li> <li><strong>2028 Projection<\/strong>: $160-180 (dominance in gene therapy and immunology)<\/li> <li><strong>2030 Vision<\/strong>: $200+ (global healthcare expansion and aging population trends)<\/li> <\/ul> <p>The consensus among analysts remains positive despite near-term patent concerns. Novartis' strategic focus on innovative medicines and recent successful clinical trials position it for sustained long-term growth.<\/p>  <h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2> <h3>Risks to Consider<\/h3> <ul> <li><strong>Patent Expirations<\/strong>: Entresto, their $2.36B quarterly drug, faces generic competition soon (<a href=\"https:\/\/www.ainvest.com\/news\/novartis-growth-slow-patent-expirations-loom-2507\/\">AInvest Report<\/a>)<\/li> <li><strong>Regulatory Pressure<\/strong>: FDA scrutiny intensifying with 907 warning letters in 2023 (+12% from 2022)<\/li> <li><strong>Pricing Reforms<\/strong>: Potential 15-20% revenue impact from US government drug pricing proposals<\/li> <li><strong>Debt Levels<\/strong>: Debt-to-equity ratio of 0.53 requires careful monitoring<\/li> <\/ul> <h3>Green Lights for 2025<\/h3> <ul> <li><strong>Strong Pipeline<\/strong>: Positive Phase 3 results for ianalumab in Sj\u00f6gren's disease and ITP<\/li> <li><strong>Strategic Acquisition<\/strong>: Completed $1.7B Regulus Therapeutics deal strengthening microRNA capabilities<\/li> <li><strong>Market Leadership<\/strong>: #5 in pharmaceutical sales globally with massive R&D investment<\/li> <li><strong>Dividend Stability<\/strong>: 3.53% yield providing income during market fluctuations<\/li> <\/ul>  <h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2> <ol> <li><strong>Start Small<\/strong>: Begin with a position size that represents no more than 5% of your portfolio<\/li> <li><strong>Dollar-Cost Average<\/strong>: Invest fixed amounts regularly rather than trying to time the market<\/li> <li><strong>Set Price Alerts<\/strong>: Monitor around November 4 earnings for potential entry points<\/li> <li><strong>Think Long-Term<\/strong>: Pharmaceutical stocks require patience\u2014this isn't a quick flip opportunity<\/li> <\/ol> <p>Humorous take: \"Trading NVS is like taking medicine\u2014sometimes it tastes bitter short-term, but it's good for your portfolio's health long-term!\"<\/p>  <h2>\u2705 How to Buy Novartis AG (NVS) Shares - Step by Step<\/h2> <table> <thead> <tr><th>Step<\/th><th>Action<\/th><th>Why It Matters<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Choose a Trading Platform<\/td><td>Ensure it offers NYSE-listed stocks and international access<\/td><\/tr> <tr><td>2<\/td><td>Complete Account Verification<\/td><td>Typically requires ID and proof of address\u2014usually takes 1-2 days<\/td><\/tr> <tr><td>3<\/td><td>Deposit Funds<\/td><td>Start with an amount you're comfortable risking\u2014even $100 can begin your journey<\/td><\/tr> <tr><td>4<\/td><td>Search for \"NVS\"<\/td><td>Use the ticker symbol, not just \"Novartis\"<\/td><\/tr> <tr><td>5<\/td><td>Select Order Type<\/td><td>Use limit orders to control your entry price rather than market orders<\/td><\/tr> <tr><td>6<\/td><td>Review and Confirm<\/td><td>Check commission fees\u2014aim for less than 1% of your trade value<\/td><\/tr> <tr><td>7<\/td><td>Monitor Your Position<\/td><td>Set price alerts and review company news regularly<\/td><\/tr> <\/tbody> <\/table>  <h2>\ud83d\udca1 Why Pocket Option Fits New Investors<\/h2> <p>For those starting their investment journey, Pocket Option offers exceptional accessibility:<\/p> <ul> <li><strong>Minimum deposit: $5<\/strong>\u2014perfect for testing strategies with minimal risk<\/li> <li><strong>Rapid verification<\/strong>: Single-document KYC process completed in minutes<\/li> <li><strong>Global access<\/strong>: Trade US stocks from anywhere in the world<\/li> <li><strong>Educational resources<\/strong>: Comprehensive learning materials on the <a href=\"\/blog\">Pocket Option blog<\/a><\/li> <\/ul> <p>The platform's user-friendly interface makes entering the stock market less intimidating for beginners while providing professional-grade tools for serious investors.<\/p>  <h2>\ud83c\udf0d Novartis in 2025: Healthcare Innovation Leader<\/h2> <p>Novartis dominates as a pure-play innovative medicines company, having transformed from a diversified pharmaceutical giant into a focused innovation powerhouse. The company reached 296 million patients worldwide in 2025 while maintaining relentless focus on four core therapeutic areas: cardiovascular-renal-metabolic diseases, immunology, neuroscience, and oncology.<\/p> <p><strong>2025 Interesting Fact<\/strong>: Novartis completed the spin-off of its Sandoz generics business in late 2023, creating a leaner, more focused company that's now pouring billions into cutting-edge gene therapy and radioligand treatment research. Their Basel headquarters has become a global hub for medical innovation that's literally changing how we treat serious diseases.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Novartis Stock Analysis: Current Price and Market Position<\/h2>\n<p>As of August 24, 2025, Novartis AG (NVS) trades at <strong>$126.98<\/strong>\u2014a strong position reflecting the company&#8217;s solid performance and market confidence. This Swiss pharmaceutical giant isn&#8217;t just another stock; it&#8217;s a cornerstone of global healthcare innovation.<\/p>\n<p><strong>Mark Your Calendar: November 4, 2025<\/strong> is your next critical date. That&#8217;s when Novartis releases its Q3 earnings report, and historically, these announcements create significant price movements. The company&#8217;s last earnings on July 17, 2025, showed impressive results with double-digit sales growth and core margin expansion.<\/p>\n<h3>How Earnings Reports Impact NVS Stock<\/h3>\n<table>\n<thead>\n<tr>\n<th>Date<\/th>\n<th>Event<\/th>\n<th>Price Impact<\/th>\n<th>Duration<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>July 17, 2025<\/td>\n<td>Q2 Earnings Beat<\/td>\n<td>+3.2%<\/td>\n<td>2 days<\/td>\n<\/tr>\n<tr>\n<td>April 22, 2025<\/td>\n<td>Q1 Results<\/td>\n<td>+2.1%<\/td>\n<td>1 week<\/td>\n<\/tr>\n<tr>\n<td>February 5, 2025<\/td>\n<td>Annual Report<\/td>\n<td>+4.8%<\/td>\n<td>3 days<\/td>\n<\/tr>\n<tr>\n<td>October 29, 2024<\/td>\n<td>Q3 Earnings<\/td>\n<td>-1.5%<\/td>\n<td>Minor dip<\/td>\n<\/tr>\n<tr>\n<td>July 18, 2024<\/td>\n<td>Q2 Results<\/td>\n<td>+3.6%<\/td>\n<td>Sustained growth<\/td>\n<\/tr>\n<tr>\n<td>April 23, 2024<\/td>\n<td>Q1 Performance<\/td>\n<td>+2.3%<\/td>\n<td>Steady climb<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The pattern shows Novartis typically experiences positive momentum after strong earnings, with occasional minor corrections that often present buying opportunities.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6-Month Price Journey: January-August 2025<\/h2>\n<p>Novartis shares have demonstrated remarkable resilience and growth over the past six months:<\/p>\n<ul>\n<li><strong>January 2025<\/strong>: Started around $96.91, surged +7.61% as investors recognized the company&#8217;s restructuring benefits<\/li>\n<li><strong>February 2025<\/strong>: Continued momentum with +4.13% growth, reaching $113 high on strong product pipeline news<\/li>\n<li><strong>March 2025<\/strong>: Steady +2.23% gain as market digested Q1 expectations<\/li>\n<li><strong>April 2025<\/strong>: Volatile period (+1.80%) with wider swings between $97.72-$114.70<\/li>\n<li><strong>May 2025<\/strong>: Solid +2.00% growth amid positive clinical trial results<\/li>\n<li><strong>June 2025<\/strong>: Strong +4.54% rebound as acquisition news boosted confidence<\/li>\n<li><strong>July 2025<\/strong>: Minor correction of -3.62% due to profit-taking after strong run<\/li>\n<li><strong>August 2025<\/strong>: Recovery to current $126.98, showing investor confidence<\/li>\n<\/ul>\n<p><strong>Total 6-month gain: Approximately 28%<\/strong>\u2014outperforming many pharmaceutical peers and demonstrating why NVS remains a favorite among growth investors.<\/p>\n<h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2>\n<p>Based on current analyst projections and company performance, here&#8217;s what to expect:<\/p>\n<ul>\n<li><strong>2025 Year-End<\/strong>: $129-135 (strong holiday quarter and pipeline developments) \u2192 <strong>BUY<\/strong><\/li>\n<li><strong>2026 Target<\/strong>: $140-150 (successful integration of recent acquisitions)<\/li>\n<li><strong>2028 Projection<\/strong>: $160-180 (dominance in gene therapy and immunology)<\/li>\n<li><strong>2030 Vision<\/strong>: $200+ (global healthcare expansion and aging population trends)<\/li>\n<\/ul>\n<p>The consensus among analysts remains positive despite near-term patent concerns. Novartis&#8217; strategic focus on innovative medicines and recent successful clinical trials position it for sustained long-term growth.<\/p>\n<h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2>\n<h3>Risks to Consider<\/h3>\n<ul>\n<li><strong>Patent Expirations<\/strong>: Entresto, their $2.36B quarterly drug, faces generic competition soon (<a href=\"https:\/\/www.ainvest.com\/news\/novartis-growth-slow-patent-expirations-loom-2507\/\">AInvest Report<\/a>)<\/li>\n<li><strong>Regulatory Pressure<\/strong>: FDA scrutiny intensifying with 907 warning letters in 2023 (+12% from 2022)<\/li>\n<li><strong>Pricing Reforms<\/strong>: Potential 15-20% revenue impact from US government drug pricing proposals<\/li>\n<li><strong>Debt Levels<\/strong>: Debt-to-equity ratio of 0.53 requires careful monitoring<\/li>\n<\/ul>\n<h3>Green Lights for 2025<\/h3>\n<ul>\n<li><strong>Strong Pipeline<\/strong>: Positive Phase 3 results for ianalumab in Sj\u00f6gren&#8217;s disease and ITP<\/li>\n<li><strong>Strategic Acquisition<\/strong>: Completed $1.7B Regulus Therapeutics deal strengthening microRNA capabilities<\/li>\n<li><strong>Market Leadership<\/strong>: #5 in pharmaceutical sales globally with massive R&#038;D investment<\/li>\n<li><strong>Dividend Stability<\/strong>: 3.53% yield providing income during market fluctuations<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2>\n<ol>\n<li><strong>Start Small<\/strong>: Begin with a position size that represents no more than 5% of your portfolio<\/li>\n<li><strong>Dollar-Cost Average<\/strong>: Invest fixed amounts regularly rather than trying to time the market<\/li>\n<li><strong>Set Price Alerts<\/strong>: Monitor around November 4 earnings for potential entry points<\/li>\n<li><strong>Think Long-Term<\/strong>: Pharmaceutical stocks require patience\u2014this isn&#8217;t a quick flip opportunity<\/li>\n<\/ol>\n<p>Humorous take: &#8220;Trading NVS is like taking medicine\u2014sometimes it tastes bitter short-term, but it&#8217;s good for your portfolio&#8217;s health long-term!&#8221;<\/p>\n<h2>\u2705 How to Buy Novartis AG (NVS) Shares &#8211; Step by Step<\/h2>\n<table>\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose a Trading Platform<\/td>\n<td>Ensure it offers NYSE-listed stocks and international access<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Complete Account Verification<\/td>\n<td>Typically requires ID and proof of address\u2014usually takes 1-2 days<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Deposit Funds<\/td>\n<td>Start with an amount you&#8217;re comfortable risking\u2014even $100 can begin your journey<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Search for &#8220;NVS&#8221;<\/td>\n<td>Use the ticker symbol, not just &#8220;Novartis&#8221;<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Select Order Type<\/td>\n<td>Use limit orders to control your entry price rather than market orders<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Review and Confirm<\/td>\n<td>Check commission fees\u2014aim for less than 1% of your trade value<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Monitor Your Position<\/td>\n<td>Set price alerts and review company news regularly<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Why Pocket Option Fits New Investors<\/h2>\n<p>For those starting their investment journey, Pocket Option offers exceptional accessibility:<\/p>\n<ul>\n<li><strong>Minimum deposit: $5<\/strong>\u2014perfect for testing strategies with minimal risk<\/li>\n<li><strong>Rapid verification<\/strong>: Single-document KYC process completed in minutes<\/li>\n<li><strong>Global access<\/strong>: Trade US stocks from anywhere in the world<\/li>\n<li><strong>Educational resources<\/strong>: Comprehensive learning materials on the <a href=\"\/blog\">Pocket Option blog<\/a><\/li>\n<\/ul>\n<p>The platform&#8217;s user-friendly interface makes entering the stock market less intimidating for beginners while providing professional-grade tools for serious investors.<\/p>\n<h2>\ud83c\udf0d Novartis in 2025: Healthcare Innovation Leader<\/h2>\n<p>Novartis dominates as a pure-play innovative medicines company, having transformed from a diversified pharmaceutical giant into a focused innovation powerhouse. The company reached 296 million patients worldwide in 2025 while maintaining relentless focus on four core therapeutic areas: cardiovascular-renal-metabolic diseases, immunology, neuroscience, and oncology.<\/p>\n<p><strong>2025 Interesting Fact<\/strong>: Novartis completed the spin-off of its Sandoz generics business in late 2023, creating a leaner, more focused company that&#8217;s now pouring billions into cutting-edge gene therapy and radioligand treatment research. Their Basel headquarters has become a global hub for medical innovation that&#8217;s literally changing how we treat serious diseases.<\/p>\n"},"faq":[{"question":"Is now a good time to buy NVS stock?","answer":"Current analyst consensus suggests a \"Hold\" rating with moderate upside potential. The upcoming November earnings could provide better entry points if the stock experiences its typical post-earnings volatility."},{"question":"What dividend does Novartis pay?","answer":"Novartis offers a solid 3.53% dividend yield, providing income stability while you wait for capital appreciation. The company has a history of maintaining and growing dividends."},{"question":"How does patent expiration affect NVS stock?","answer":"Patent expirations can create short-term pressure as generic competition emerges, but Novartis' strong pipeline typically offsets these losses over time through new drug launches."},{"question":"What makes Novartis different from other pharmaceutical stocks?","answer":"Novartis' pure-play innovative medicine focus, massive R&D budget ($9.5B annually), and leadership in gene therapies create a unique growth profile compared to more diversified pharma companies."},{"question":"How often does Novartis report earnings?","answer":"Quarterly\u2014typically in February (Q4), April (Q1), July (Q2), and October\/November (Q3). These dates are crucial for monitoring company performance and making investment decisions."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Is now a good time to buy NVS stock?","answer":"Current analyst consensus suggests a \"Hold\" rating with moderate upside potential. The upcoming November earnings could provide better entry points if the stock experiences its typical post-earnings volatility."},{"question":"What dividend does Novartis pay?","answer":"Novartis offers a solid 3.53% dividend yield, providing income stability while you wait for capital appreciation. The company has a history of maintaining and growing dividends."},{"question":"How does patent expiration affect NVS stock?","answer":"Patent expirations can create short-term pressure as generic competition emerges, but Novartis' strong pipeline typically offsets these losses over time through new drug launches."},{"question":"What makes Novartis different from other pharmaceutical stocks?","answer":"Novartis' pure-play innovative medicine focus, massive R&D budget ($9.5B annually), and leadership in gene therapies create a unique growth profile compared to more diversified pharma companies."},{"question":"How often does Novartis report earnings?","answer":"Quarterly\u2014typically in February (Q4), April (Q1), July (Q2), and October\/November (Q3). These dates are crucial for monitoring company performance and making investment decisions."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy Novartis AG (NVS) shares - Investment in Novartis AG (NVS) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-novartis-ag\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy Novartis AG (NVS) shares - Investment in Novartis AG (NVS) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-novartis-ag\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-24T13:41:01+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-novartis-ag\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-novartis-ag\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy Novartis AG (NVS) shares &#8211; Investment in Novartis AG (NVS) stock\",\"datePublished\":\"2025-08-24T13:41:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-novartis-ag\/\"},\"wordCount\":15,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-novartis-ag\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-novartis-ag\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-novartis-ag\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-novartis-ag\/\",\"name\":\"How to buy Novartis AG (NVS) shares - Investment in Novartis AG (NVS) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-novartis-ag\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-novartis-ag\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"datePublished\":\"2025-08-24T13:41:01+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-novartis-ag\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-novartis-ag\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-novartis-ag\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"width\":1408,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-novartis-ag\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy Novartis AG (NVS) shares &#8211; Investment in Novartis AG (NVS) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy Novartis AG (NVS) shares - Investment in Novartis AG (NVS) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-novartis-ag\/","og_locale":"en_US","og_type":"article","og_title":"How to buy Novartis AG (NVS) shares - Investment in Novartis AG (NVS) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-novartis-ag\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-24T13:41:01+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-novartis-ag\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-novartis-ag\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy Novartis AG (NVS) shares &#8211; Investment in Novartis AG (NVS) stock","datePublished":"2025-08-24T13:41:01+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-novartis-ag\/"},"wordCount":15,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-novartis-ag\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-novartis-ag\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-novartis-ag\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-novartis-ag\/","name":"How to buy Novartis AG (NVS) shares - Investment in Novartis AG (NVS) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-novartis-ag\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-novartis-ag\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","datePublished":"2025-08-24T13:41:01+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-novartis-ag\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-novartis-ag\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-novartis-ag\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","width":1408,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-novartis-ag\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy Novartis AG (NVS) shares &#8211; Investment in Novartis AG (NVS) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":344689,"slug":"how-to-buy-novartis-ag","post_title":"Comment acheter des actions Novartis AG (NVS) - Investir dans les actions Novartis AG (NVS)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-novartis-ag\/"},"it_IT":{"locale":"it_IT","id":344688,"slug":"how-to-buy-novartis-ag","post_title":"Come acquistare azioni Novartis AG (NVS) - Investire in azioni Novartis AG (NVS)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-novartis-ag\/"},"pl_PL":{"locale":"pl_PL","id":344693,"slug":"how-to-buy-novartis-ag","post_title":"Jak kupi\u0107 akcje Novartis AG (NVS) - Inwestycja w akcje Novartis AG (NVS)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-novartis-ag\/"},"es_ES":{"locale":"es_ES","id":344691,"slug":"how-to-buy-novartis-ag","post_title":"C\u00f3mo comprar acciones de Novartis AG (NVS) - Inversi\u00f3n en acciones de Novartis AG (NVS)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-novartis-ag\/"},"th_TH":{"locale":"th_TH","id":344695,"slug":"how-to-buy-novartis-ag","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 Novartis AG (NVS) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 Novartis AG (NVS)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-novartis-ag\/"},"tr_TR":{"locale":"tr_TR","id":344692,"slug":"how-to-buy-novartis-ag","post_title":"Novartis AG (NVS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Novartis AG (NVS) Hisse Senedi Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-novartis-ag\/"},"vt_VT":{"locale":"vt_VT","id":344694,"slug":"how-to-buy-novartis-ag","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Novartis AG (NVS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Novartis AG (NVS)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-novartis-ag\/"},"pt_AA":{"locale":"pt_AA","id":344690,"slug":"how-to-buy-novartis-ag","post_title":"Como comprar a\u00e7\u00f5es da Novartis AG (NVS) - Investimento em a\u00e7\u00f5es da Novartis AG (NVS)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-novartis-ag\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/344661","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=344661"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/344661\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334027"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=344661"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=344661"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=344661"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}